Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation

Fertility and Sterility

Volumn 67, Issue 6, 1997, Pages 1046-1053

  Cameron, Sharon T ^b   Kelly, Rodney W ^b   Critchley, Hilary O D ^b   Baird, David T ^a   Buckley, C Hilary ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NONE

Author keywords

Endometrium; Implantation; Leukemia inhibitory factor; Mifepristone; Onapristone; Prostaglandins; RU486

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ANTIGESTAGEN; KI 67 ANTIGEN; LEUKEMIA INHIBITORY FACTOR; LUTEINIZING HORMONE; MIFEPRISTONE; ONAPRISTONE; PLACENTA PROTEIN 14;

ADULT; ARTICLE; BIRTH CONTROL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM BIOPSY; ENDOMETRIUM CYTOLOGY; FEMALE; HUMAN; HUMAN TISSUE; LUTEAL PHASE; LUTEINIZING HORMONE RELEASE; NIDATION; ORAL DRUG ADMINISTRATION; OVARY CYCLE; OVULATION; PRIORITY JOURNAL;

EID: 0343488606     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81437-9     Document Type: Article

References (23)

1. Johanisson E. Morphological and histochemical factors related to implantation. Ballièrés Clin Obstet Gynaecol 1991;5:191-210.
2. Neef G, Beier S, Elger W, Henderson R. New steroids with antiprogestational and antiglucocorticoid activities. Steroids 1984;44:349-72.
3. Swahn M-L, Bygdeman M, Cekan S, Xing S, Masironi B, Johanisson E. The effect of RU 486 administered during the early luteal phase on bleeding, hormonal parameters and endometrium. Hum Reprod 1990;5:402-8.
4. Gemzell-Danielsson K, Svalander P, Swahn M-L, Johannisson E, Bygdeman M. Effects of a single post-ovulatory dose of RU 486 on endometrial maturation in the implantation phase. Hum Reprod 1994;9:2398-404.
5. Cameron ST, Critchley HOD, Buckley CH, Chard T, Kelly RW, Baird DT. The effects of post-ovulatory administration of onapristone on the development of a secretory endometrium. Hum Reprod 1996;11:40-9.
6. Ferenczy A, Bertrand G, Gelfand MM. Proliferation kinetics of human endometrium throughout the normal menstrual cycle. Am J Obstet Gynecol 1979;133:859-67.
7. Gerdes J, Li L, Schuelter C, Duchrow M, Wohlenberg C, Gerlach C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation associated nuclear antigen that is denned by monoclonal antibody Ki 67. Am J Pathol 1991;138:867-73.
8. Charnock-Jones DS, Sharkey AM, Fenwick P, Smith SK. Leukemia inhibitory factor mRNA in human endometrium around the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil 1994;101:412-26.
9. Vogiagis D, Marsh MM, Fry RC, Salmonsen LA. Leukemia inhibitory factor in human endometrium throughout the menstrual cycle. J Endocrinol 1996;148:95-102.
10. + dependent 15-hydroxyprostaglandin dehydrogenase in human endometrium. Prostaglandins 1980;19:115-22.
11. Bolton AE, Clough KJ, Stoker RJ, Pockley AG, Mowles EA, Westwood OMR, et al. Identification of placental protein 14 as an immunosuppressive factor in human reproduction. Lancet 1987;14:693-5.
12. Okamoto N, Uchida A, Takakura K, Kariya Y, Kannzaki H, Riitinen L, et al. Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol 1991;26:137-42.
13. Chard T, Olajide F. Endometrial protein 14: a new test of endometrial function? Reprod Med Rev 1994;3:43-52.
14. Yong EL, Glasier A, Hillier H, Ledger W, Caird L, Beattie G, et al. Effect of cyclofenil on hormonal dynamics, follicular development and cervical mucus in normal and oligomenorrheic women. Hum Reprod 1992;7:39-43.
15. Howell RJS, Economides D, Teisner B, Farkas AG, Chard T. Placental proteins 12 and 14 in pre-eclampsia. Acta Obstet Gynecol Scand 1989;68:237-40.
16. Noyes RW, Hertig DT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
17. Hertig AT, Rock J, Adam E. A description of 34 human ova within the first 17 days of development. Am J Anat 1956;98:435-93.
18. Johki PP, King A, Sharkey AM, Smith SK, Loke YW. Screening for cytokine mRNA's in purified human decidual lymphoid populations by reverse transcriptase polymerase chain reaction (RT-PCR). J Immunol 1994;153:4427-35.
19. Stewart CL, Kaspar P, Brunet LJ, Bhat H, Hadi I, Kontgen F, et al. Blastocyst implantation depends on maternal expression of LIF. Nature 1992;357:76-9.
20. Dunglison GF, Barlow DH, Sargent IL. Leukemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free medium. Hum Reprod 1996;11:191-6.
21. Arici A, Engin O, Attar E, Olive DL. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 1995;80:1908-15.
22. Glasier A, Thong KJ, Dewar M, Mackie M, Baird DT. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency post-coital contraception. N Engl J Med 1992;327:1041-4.
23. Gemzell-Danielsson K, Swahn M-L, Svalander P, Bygdeman M. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Hum Reprod 1993;8:870-3.